These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 28933669

  • 1. Broad perspectives of allergen specific immunotherapy.
    Thomas WR.
    Hum Vaccin Immunother; 2017 Oct 03; 13(10):2385-2389. PubMed ID: 28933669
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Specific immunotherapy in allergies--evaluation of current status].
    Jarisch R, Hemmer W.
    Wien Med Wochenschr; 1996 Oct 03; 146(15):422-5. PubMed ID: 9012204
    [Abstract] [Full Text] [Related]

  • 8. Intralymphatic immunotherapy: from the rationale to human applications.
    Senti G, Johansen P, Kündig TM.
    Curr Top Microbiol Immunol; 2011 Oct 03; 352():71-84. PubMed ID: 21725898
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Allergen-specific immunotherapy: current concepts and future directions.
    Bieber T, Simon HU.
    Allergy; 2011 Jun 03; 66(6):709-12. PubMed ID: 21518373
    [No Abstract] [Full Text] [Related]

  • 12. [Hyposensitization].
    Przybilla B, Ring J.
    Internist (Berl); 1991 Oct 03; 32(10):606-11. PubMed ID: 1761393
    [No Abstract] [Full Text] [Related]

  • 13. Immunological mechanisms of allergen-specific immunotherapy.
    Larché M, Akdis CA, Valenta R.
    Nat Rev Immunol; 2006 Oct 03; 6(10):761-71. PubMed ID: 16998509
    [Abstract] [Full Text] [Related]

  • 14. Immunological mechanisms operative in allergen-specific immunotherapy.
    Ebner C.
    Int Arch Allergy Immunol; 1999 May 03; 119(1):1-5. PubMed ID: 10341314
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera).
    Di Bona D, Albanesi M, Giliberti LA, Nico A, Rossi MP, Caiaffa MF, Macchia L.
    J Allergy Clin Immunol Pract; 2017 May 03; 5(3):821-822. PubMed ID: 27888036
    [No Abstract] [Full Text] [Related]

  • 18. Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy.
    Schöll I, Kopp T, Bohle B, Jensen-Jarolim E.
    Immunol Allergy Clin North Am; 2006 May 03; 26(2):349-64, ix. PubMed ID: 16701149
    [Abstract] [Full Text] [Related]

  • 19. Immunological responses to allergen immunotherapy.
    Till SJ, Durham SR.
    Clin Allergy Immunol; 2004 May 03; 18():85-104. PubMed ID: 15042910
    [No Abstract] [Full Text] [Related]

  • 20. Immunological mechanisms of sublingual allergen-specific immunotherapy.
    Novak N, Bieber T, Allam JP.
    Allergy; 2011 Jun 03; 66(6):733-9. PubMed ID: 21251016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.